OMER
$16.55+1.22%
Omeros CorporationStock · HealthcareRussell 2000 · 0.02% of IWMNasdaq Composite · 0.003% of ONEQRussell 3000 · 0.0010% of IWVUS Stock Market · 0.0009% of VTI
OMER — Omeros Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
5.010.015.020.025.00100.0M$16.55—20162019202120242026
2026-10-20
Price$16.55
MA20$14.27
MA50$11.44
Vol7.0M
Key stats#
Price data
- Price
- $16.55
- YTD price return
- -3.67%
- YTD total return
- -3.67%
- Next earnings
- Nov 12, 2026
- Market cap
- 1.2B
- Enterprise value
- 1.1B
- Shares outstanding
- 72.4M
- 52W low
- $6.24
- 52W high
- $21.24
- From 52W high
- -22.08%
- From 52W low
- +165.22%
- 52W range
- 69%
Volume
- Rel volume
- 0.52×
- 30D volume
- 1.4M
- 30D $ vol
- 26M
Fundamentals
- EPS (ttm)
- $1.39
- FCF (ttm)
- -68.7M
- FCF/share
- -$0.95
- Book value/share
- -$0.71
- ROA
- 43.52%
- Current ratio
- 1.95
Growth (CAGR, ttm) · 10Y
- Sales
- -6.30%+61.18%+20.67%n/a
- Net income
- n/a+45.78%n/an/a
- Shares
- +6.37%+4.82%+2.98%+6.30%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- n/a+29.48%n/an/a
- Sales/share
- -7.63%+48.60%+11.91%n/a
- Price
- +100.70%+137.80%+20.93%+8.08%
- Total return
- +100.70%+137.80%+20.93%+8.08%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 11.9×
- Fwd P/E
- 13.3×
- P/B (mrq)
- -23.3×
- FCF yield (ttm)
- -5.74%
- Buyback yield (realized, 1y)
- -6.37%
- Shareholder yield (realized, 1y)
- -6.37%
- Buyback yield (cash, ttm)
- 1.35%
- Shareholder yield (cash, ttm)
- 1.35%
Vs own 10Y history
- P/S
- 74th
Bar = where today’s multiple sits in OMER’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-20#
1D
+1.22%
5D
-12.34%
1M
-7.39%
3M
+71.86%
YTD
-3.67%
1Y
+100.61%
5Y
+158.59%
Financial statements
Open full OMER financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
